{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:39Z","timestamp":1787010099916,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Despite the growing acceptance of left ventricular assist device (LVAD) therapy to improve survival and quality of life in heart failure (HF) patients, uncertainties persist regarding the definition of a successful implant. We sought to define an innovative approach to assess success and subsequently compare preoperative variables affecting outcomes. From January 2007 to 2015, 278 patients underwent LVAD implantation. Median age at implant was 62 years and 81% patients were males. Indication for support was bridge-to-transplantation in 36% patients and the etiology of HF was ischemic in 49% patients. Based on clinically relevant and accepted standards, we defined successful LVAD implant as someone who was alive or transplanted at 2 years, had two or less readmissions in the first year, had no major adverse events in the first year, and had a New York Heart Association class of \u2264 II at 6 months. Follow-up was obtained for a median of 1.7 years for a total of 605 patient-years-of-support. Based on our criteria, 81\/278 (29%) patients were defined as having a successful implant. Univariate predictors of LVAD failure included destination therapy indication (hazard ratio [HR] = 2.11 [1.24, 3.58]), ischemic cardiomyopathy (HR = 1.73 [1.02, 2.94]), and a higher left ventricular ejection fraction (HR = 1.54 [1.07, 2.22]). After multivariable analysis, only destination therapy indication (HR = 2.2 [1.28, 3.78]) was found to be independently predictive of success failure. Despite an overall trend toward improved outcomes on device therapy, our criteria classified only one-third of patients as successful. Continued improvements in adverse event profiles, appropriate patient selection, and optimal time of implantation, together hold the key to improve outcomes after LVAD therapy.<\/jats:p>","DOI":"10.1097\/mat.0000000000000894","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T03:08:11Z","timestamp":1539313691000},"page":"430-435","source":"Crossref","is-referenced-by-count":9,"title":["Left Ventricular Assist Devices: How Do We Define Success?"],"prefix":"10.1097","volume":"65","author":[{"given":"Lucman A.","family":"Anwer","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of General Surgery, University of Illinois at Chicago\/Metropolitan Group of Hospitals, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Poddi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vakhtang","family":"Tchantchaleishvili","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Toeg","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Strand","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Stulak","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Maltais","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230821","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2012.12.004","article-title":"Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients.","volume":"32","author":"Kirklin","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R2-20230821","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device.","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-20230821","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 Patients and counting.","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R4-20230821","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semtcvs.2013.02.002","article-title":"Current status of left ventricular assist device technology.","volume":"25","author":"Molina","year":"2013","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R5-20230821","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.healun.2013.11.001","article-title":"Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R6-20230821","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.athoracsur.2013.07.004","article-title":"Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.","volume":"96","author":"Stulak","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R7-20230821","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCHEARTFAILURE.111.963991","article-title":"Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.","volume":"5","author":"Park","year":"2012","journal-title":"Circ Heart Fail"},{"key":"R8-20230821","doi-asserted-by":"crossref","DOI":"10.1097\/MAT.0000000000000585","article-title":"Adverse event rates change favorably over time for patients bridged with the HeartWare left ventricular assist device.","author":"Maltais","year":"2017","journal-title":"ASAIO J"},{"key":"R9-20230821","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis.","volume":"370","author":"Starling","year":"2014","journal-title":"N Engl J Med"},{"key":"R10-20230821","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.healun.2009.05.018","article-title":"Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation.","volume":"28","author":"Boyle","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R11-20230821","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2010.02.003","article-title":"Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R12-20230821","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.athoracsur.2013.05.081","article-title":"Surgical technique influences HeartMate II left ventricular assist device thrombosis.","volume":"96","author":"Taghavi","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R13-20230821","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healun.2013.10.005","article-title":"Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: A multifactorial phenomenon.","volume":"33","author":"Uriel","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R14-20230821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2016.10.001","article-title":"PREVENtion of HeartMate II pump thrombosis through clinical management: The PREVENT multi-center study.","volume":"36","author":"Maltais","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R15-20230821","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure.","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"R16-20230821","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.healun.2014.04.010","article-title":"Sixth INTERMACS annual report: A 10,000-patient database.","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R17-20230821","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation.","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"R18-20230821","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/eurheartj\/ehx036","article-title":"The burden of haemocompatibility with left ventricular assist systems: A complex weave.","volume":"40","author":"Mehra","year":"2017","journal-title":"Eur Heart J"},{"key":"R19-20230821","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.healun.2015.10.024","article-title":"Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R20-20230821","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R21-20230821","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jtcvs.2015.09.100","article-title":"Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.","volume":"151","author":"Stulak","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R22-20230821","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/jocs.12158","article-title":"Clinical differences between continuous flow ventricular assist devices: A comparison between HeartMate II and HeartWare HVAD.","volume":"28","author":"Lalonde","year":"2013","journal-title":"J Card Surg"},{"key":"R23-20230821","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"key":"R24-20230821","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.jacc.2015.09.083","article-title":"Fully magnetically levitated left ventricular assist system for treating advanced HF: A multicenter study.","volume":"66","author":"Netuka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R25-20230821","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.healun.2012.05.004","article-title":"Continuous-flow devices and percutaneous site infections: Clinical outcomes.","volume":"31","author":"Goldstein","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R26-20230821","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1540-8191.2011.01292.x","article-title":"Temporal changes in hospital costs for left ventricular assist device implantation.","volume":"26","author":"Slaughter","year":"2011","journal-title":"J Card Surg"},{"key":"R27-20230821","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.healun.2014.05.010","article-title":"Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.","volume":"33","author":"John","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R28-20230821","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MAT.0000000000000531","article-title":"Percutaneous driveline fracture following implantation of the HeartMate II left ventricular assist device: How durable is driveline repair?","volume":"63","author":"Stulak","year":"2017","journal-title":"ASAIO J"},{"key":"R29-20230821","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.healun.2006.12.007","article-title":"Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.","volume":"26","author":"Pae","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R30-20230821","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/erd.11.36","article-title":"Left ventricular assist device-related infections: past, present and future.","volume":"8","author":"Maniar","year":"2011","journal-title":"Expert Rev Med Devices"},{"key":"R31-20230821","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure.","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002480-201907000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:08:01Z","timestamp":1692655681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002480-201907000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000000894","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}